Cargando…
Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291517/ https://www.ncbi.nlm.nih.gov/pubmed/34691988 http://dx.doi.org/10.1093/nsr/nwz009 |
| _version_ | 1783724652011454464 |
|---|---|
| author | Wei, Xiawei Wei, Yuquan |
| author_facet | Wei, Xiawei Wei, Yuquan |
| author_sort | Wei, Xiawei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8291517 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82915172021-10-21 Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease Wei, Xiawei Wei, Yuquan Natl Sci Rev Special Topic: Chemistry and Molecular Medicine Oxford University Press 2019-11 2019-02-05 /pmc/articles/PMC8291517/ /pubmed/34691988 http://dx.doi.org/10.1093/nsr/nwz009 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of China Science Publishing & Media Ltd. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Special Topic: Chemistry and Molecular Medicine Wei, Xiawei Wei, Yuquan Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease |
| title | Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease |
| title_full | Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease |
| title_fullStr | Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease |
| title_full_unstemmed | Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease |
| title_short | Opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an RNAi nanoparticle for treatment of a rare disease |
| title_sort | opportunities and challenges in the nanoparticles for nucleic acid therapeutics: the first approval of an rnai nanoparticle for treatment of a rare disease |
| topic | Special Topic: Chemistry and Molecular Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291517/ https://www.ncbi.nlm.nih.gov/pubmed/34691988 http://dx.doi.org/10.1093/nsr/nwz009 |
| work_keys_str_mv | AT weixiawei opportunitiesandchallengesinthenanoparticlesfornucleicacidtherapeuticsthefirstapprovalofanrnainanoparticlefortreatmentofararedisease AT weiyuquan opportunitiesandchallengesinthenanoparticlesfornucleicacidtherapeuticsthefirstapprovalofanrnainanoparticlefortreatmentofararedisease |